NOVATO, Calif., Dec. 13, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq:RPTP) today announced that Christopher M. Starr, Ph.D., Raptor’s Chief Executive Officer will present an overview of the Company at the Oppenheimer 22nd Annual Healthcare Conference. Raptor’s presentation will take place at The Waldorf=Astoria Hotel in New York City on Wednesday, December 14th at 11:25am ET.
